Clinical  	Clinical  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
of  	of  	 IN	O
nervous  	nervous  	 JJ	O
system  	system  	 NN	B-NP
involvement  	involvement  	 NN	I-NP
in  	in  	 IN	O
ANCA-associated  	ANCA-associated  	 JJ	B-NP
systemic  	systemic  	 JJ	I-NP
vasculitides  	vasculitides  	 NN	I-NP
To  	To  	 TO	O
assess  	assess  	 VB	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
features  	features  	 NNS	I-NP
of  	of  	 IN	O
nervous  	nervous  	 JJ	B-NP
system  	system  	 NN	I-NP
( 	( 	 -LRB-	O
NS 	NS 	 NNP	B-NP
)  	)  	 -RRB-	O
involvement  	involvement  	 NN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
ANCA-associated  	ANCA-associated  	 JJ	B-NP
vasculitides  	vasculitides  	 NNS	I-NP
( 	( 	 -LRB-	O
AAV 	AAV 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
including  	including  	 VBG	O
microscopic  	microscopic  	 JJ	B-NP
polyangiitis  	polyangiitis  	 NNS	I-NP
( 	( 	 -LRB-	O
MPA 	MPA 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
Wegener 	Wegener 	 NNP	O
's  	's  	 POS	O
granulomatosis  	granulomatosis  	 NN	B-NP
( 	( 	 -LRB-	O
WG 	WG 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
Churg-Strauss  	Churg-Strauss  	 JJ	B-NP
syndrome  	syndrome  	 NN	I-NP
( 	( 	 -LRB-	O
CSS 	CSS 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
One  	One  	 CD	O
hundred  	hundred  	 CD	O
and  	and  	 CC	O
seventy-nine  	seventy-nine  	 JJ	O
patients  	patients  	 NNS	O
admitted  	admitted  	 VBD	O
to  	to  	 TO	O
Peking  	Peking  	 NNP	O
Union  	Union  	 NNP	O
Medical  	Medical  	 NNP	O
College  	College  	 NNP	O
Hospital  	Hospital  	 NNP	O
from  	from  	 IN	O
1995  	1995  	 CD	O
to  	to  	 TO	O
2008 	2008 	 CD	O
,  	,  	 ,	O
including  	including  	 VBG	O
93  	93  	 CD	O
cases  	cases  	 NNS	O
of  	of  	 IN	O
MPA 	MPA 	 NNP	B-NP
,  	,  	 ,	O
61  	61  	 CD	O
cases  	cases  	 NNS	O
of  	of  	 IN	O
WG 	WG 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
25  	25  	 CD	O
cases  	cases  	 NNS	O
of  	of  	 IN	O
CSS 	CSS 	 NNP	B-NP
,  	,  	 ,	O
were  	were  	 VBD	O
enrolled  	enrolled  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
.  	.  	 .	O
Medical  	Medical  	 JJ	B-NP
charts  	charts  	 NNS	I-NP
including  	including  	 VBG	O
demographic  	demographic  	 JJ	B-NP
data 	data 	 NNS	I-NP
,  	,  	 ,	O
clinical  	clinical  	 JJ	B-NP
features 	features 	 NNS	I-NP
,  	,  	 ,	O
laboratory  	laboratory  	 NN	O
findings 	findings 	 NNS	O
,  	,  	 ,	O
treatments  	treatments  	 NNS	O
and  	and  	 CC	O
outcomes  	outcomes  	 NNS	O
were  	were  	 VBD	O
systematically  	systematically  	 RB	O
reviewed 	reviewed 	 VBN	O
.  	.  	 .	O
NS  	NS  	 NNP	B-NP
involvements  	involvements  	 NN	I-NP
were  	were  	 VBD	O
observed  	observed  	 VBN	O
in  	in  	 IN	O
36.6 	36.6 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
MPA 	MPA 	 NNP	B-NP
,  	,  	 ,	O
50.8 	50.8 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
WG 	WG 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
76.0 	76.0 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
CSS  	CSS  	 NNP	B-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
Peripheral  	Peripheral  	 JJ	B-NP
neuropathy  	neuropathy  	 JJ	I-NP
predominated  	predominated  	 NN	I-NP
in  	in  	 IN	O
each  	each  	 DT	O
type  	type  	 NN	O
of  	of  	 IN	O
AAV 	AAV 	 NNP	B-NP
.  	.  	 .	O
In  	In  	 IN	O
CSS  	CSS  	 NNP	B-NP
and  	and  	 CC	O
MPA 	MPA 	 NNP	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
majority  	majority  	 NN	O
was  	was  	 VBD	O
mononeuritis  	mononeuritis  	 JJ	B-NP
multiplex  	multiplex  	 NN	I-NP
and  	and  	 CC	O
distal  	distal  	 JJ	B-NP
symmetrical  	symmetrical  	 JJ	I-NP
polyneuropathy 	polyneuropathy 	 NN	I-NP
,  	,  	 ,	O
whereas 	whereas 	 NN	O
,  	,  	 ,	O
differently 	differently 	 RB	O
,  	,  	 ,	O
64.5 	64.5 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
WG  	WG  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
with  	with  	 IN	O
NS  	NS  	 NNP	B-NP
involvement  	involvement  	 NN	I-NP
had  	had  	 VBD	O
cranial  	cranial  	 JJ	B-NP
neuropathy 	neuropathy 	 NN	I-NP
.  	.  	 .	O
Central  	Central  	 JJ	B-NP
nervous  	nervous  	 JJ	I-NP
system  	system  	 NN	I-NP
( 	( 	 -LRB-	O
CNS 	CNS 	 NNP	B-NP
)  	)  	 -RRB-	O
involvement  	involvement  	 NN	O
accounted  	accounted  	 VBD	O
for  	for  	 IN	O
21.1 	21.1 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
29.4 	29.4 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
32.3 	32.3 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
neuropathy  	neuropathy  	 VBG	O
respectively  	respectively  	 RB	O
in  	in  	 IN	O
CSS 	CSS 	 NNP	B-NP
,  	,  	 ,	O
MPA  	MPA  	 NNP	B-NP
and  	and  	 CC	O
WG  	WG  	 NNP	B-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
including  	including  	 VBG	O
arachnoid  	arachnoid  	 JJ	B-NP
hemorrhage 	hemorrhage 	 NN	I-NP
,  	,  	 ,	O
cerebrovascular  	cerebrovascular  	 JJ	B-NP
neuro-pathy 	neuro-pathy 	 NN	I-NP
,  	,  	 ,	O
meningitis 	meningitis 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
diffuse  	diffuse  	 JJ	O
brain  	brain  	 NN	O
damage.  	damage.  	 CD	O
157  	157  	 CD	O
( 	( 	 -LRB-	O
87.7 	87.7 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
AAV  	AAV  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
responded  	responded  	 VBD	O
to  	to  	 TO	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
high  	high  	 JJ	O
dose  	dose  	 NN	O
of  	of  	 IN	O
prednisone  	prednisone  	 NN	B-NP
plus  	plus  	 CC	O
immunosuppressants 	immunosuppressants 	 NN	B-NP
.  	.  	 .	O
Thirteen  	Thirteen  	 NNP	O
( 	( 	 -LRB-	O
14.0 	14.0 	 NNP	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
MPA  	MPA  	 NNP	B-NP
and  	and  	 CC	O
four  	four  	 CD	O
( 	( 	 -LRB-	O
6.6 	6.6 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
WG  	WG  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
died 	died 	 VBD	O
.  	.  	 .	O
The  	The  	 DT	O
leading  	leading  	 JJ	O
causes  	causes  	 NNS	O
of  	of  	 IN	O
death  	death  	 NN	O
were  	were  	 VBD	O
diffuse  	diffuse  	 FW	B-NP
alveolar  	alveolar  	 FW	I-NP
hemorrhage  	hemorrhage  	 FW	I-NP
( 	( 	 -LRB-	O
DAH 	DAH 	 NNP	B-NP
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
6 	6 	 CD	O
,  	,  	 ,	O
35.3 	35.3 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
infection  	infection  	 NN	B-NP
( 	( 	 -LRB-	O
6 	6 	 CD	O
,  	,  	 ,	O
35.3 	35.3 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
No  	No  	 DT	O
patient  	patient  	 NN	O
died  	died  	 VBD	O
directly  	directly  	 RB	O
of  	of  	 IN	O
neuropathy 	neuropathy 	 NN	B-NP
.  	.  	 .	O
NS  	NS  	 NNP	B-NP
involvement  	involvement  	 NN	I-NP
was  	was  	 VBD	O
common  	common  	 JJ	O
in  	in  	 IN	O
AAVs  	AAVs  	 JJ	O
and  	and  	 CC	O
the  	the  	 DT	O
characteristic  	characteristic  	 NN	O
of  	of  	 IN	O
NS  	NS  	 NNP	B-NP
involvement  	involvement  	 NN	I-NP
was  	was  	 VBD	O
different  	different  	 JJ	O
among  	among  	 IN	O
MPA 	MPA 	 NNP	B-NP
,  	,  	 ,	O
WG  	WG  	 NNP	B-NP
and  	and  	 CC	O
CSS  	CSS  	 NNP	B-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
DAH  	DAH  	 NNP	B-NP
and  	and  	 CC	O
infection  	infection  	 NN	B-NP
instead  	instead  	 RB	O
of  	of  	 IN	O
NS  	NS  	 NNP	B-NP
damage  	damage  	 NN	I-NP
remained  	remained  	 VBD	O
the  	the  	 DT	O
leading  	leading  	 JJ	O
causes  	causes  	 NNS	O
of  	of  	 IN	O
death  	death  	 NN	O
in  	in  	 IN	O
AAVs 	AAVs 	 JJ	O
.  	.  	 .	O
